Obstructive Sleep Apnea Syndrome and Metabolic Diseases.
Obstructive Sleep Apnea Syndrome and Metabolic Diseases.
Endocrinology. 2018 May 18;:
Authors: Li M, Li X, Lu Y
Abstract
With the rapid changes of lifestyle in modern society, including high nutritional intake and reduced physical activity, the incidence of metabolic diseases is increasing year by year. Obstructive sleep apnea syndrome (OSAS) is a sleep disorder, usually characterized by sudden pauses of breathing during sleep with interrupted sleep rhythm. Although the pathological mechanism remains poorly understood, it is strongly associated with metabolic diseases, including obesity, insulin resistance, type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). In this mini-review, we briefly summarizes the connections between OSAS, obesity, T2DM and NAFLD, which may help to better understand the pathogenesis of human diseases.
PMID: 29788220 [PubMed - as supplied by publisher]
Source: Endocrinology - Category: Endocrinology Authors: Li M, Li X, Lu Y Tags: Endocrinology Source Type: research
More News: Alcoholism | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Insulin | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Obesity | Obstructive Sleep Apnea | Sleep Apnea | Sleep Disorders | Sleep Medicine | Urology & Nephrology